Hi ,

In this week’s newsletter, you can learn about Sherlock Biosciences’ quest for instrument-free diagnostics, the first 100%-meat cultivated steak, and SynBioBeta’s new partnership with the BCG’s Deep Tech group. 

I’m honored to be joined by the UK Member of Parliament Chi Onwurah, the Shadow Minister for Science Research and Innovation, who will be speaking at SynBioBeta this year.

• Sherlock Biosciences nabs Sense Biodetection to expand CRISPR diagnostic reach. Sherlock adds Sense’s instrument-free molecular diagnostics platform to complement its CRISPR-based screening technology with the goal of providing simple tests for a variety of conditions that can be completed virtually anywhere.
• 3DBT says it has developed the first truly 100% cultivated meat steak. UK-based biotech company 3D Bio-Tissues (3DBT) claims to have made the world’s first "100% meat" cultivated steak grown without plant-based scaffolds that other companies have used.

Photo by 3D Bio-Tissues.

• Evonetix closes $24 million financing in an oversubscribed round led by Foresite Capital. The investment will fuel the development of Evonetix’s semiconductor technology which enables accurate synthesis of thousands of sequences on a single chip and assembly of gene-length DNA in days rather than weeks.

• Slingshot Biosciences announces $11 million in Series A3 financing to accelerate the commercialization of its synthetic cell platform for a range of applications in diagnostics and therapeutics.

• Twist Bioscience reports fiscal first quarter 2023 financial results. Total revenues for the first quarter of fiscal 2023 were $54.2 million compared to $42.0 million for the same period of fiscal 2022.

• Motif FoodWorks adds bioprocessing services to their menu. The company also celebrates the grand opening of their new market research development center, Motif’s Plant Base.

New SynBioBeta 2023 speakers announced:

• Nicole Richards is the CEO of Allonnia, the bio-ingenuity company dedicated to extracting value where others see waste.

• Patricia Bubner is the founder and the CEO of Orbillion Bio, bringing premium cell-cultured meats to the market.

• Ebihara Takashi is COO of GeneFrontier, which provides products, services, and technologies in protein engineering and drug discovery.

• Claire Aldridge is the Chief Strategy Officer of Form Bio, a Colossal Biosciences spin-out empowering scientists to harness data, computing power and collaboration to drive breakthroughs.

SynBioBeta to Partner with BCG

I’m excited to announce our new annual partnership with our friends at BCG’s Deep Tech group. You’ll be able to meet them at SynBioBeta in May.

BCG X.Deep Tech leverages proprietary design methodology for solving real-world challenges—from the food and agriculture to the GHG emissions crisis. We help clients become disruptors in their industries by driving sustainable business model transformations, redesigning products and processes, and reshaping how they interact with their customers. Our design methodology combines emerging technologies—synthetic biology, quantum computing, architected materials, robotics, AI, etc.—and tailors their use to the client’s challenge at hand. To build those competitive solutions, our world-class technologist work jointly with the venture ecosystem and senior client stakeholders. Together, we bring the best of risk-taking, strategy, scale, and market access to the table, enabling us to ideate and test promising solutions in an accelerated manner. The result is a true win-win collaboration between incumbents and emerging players.

We’ll be sending our first biopharma newsletter tomorrow: if you are interested in the intersection of synbio and human health, or want the inside story on the news and views from the thought leaders in the field from Fiona Mischel, then you can sign up here.

Environment news

• Michroma closes $6.4m seed round. The company is developing its novel technology for food colorings and flavorings that uses precision fermentation to scale fungal food colors.
• How CRISPR could help save crops from devastation caused by pests. Gene edited insects could help reduce reliance on pesticides—and help protect billion-dollar industries.
• Bioweg and Ginkgo Bioworks announce partnership to develop cost effective and efficacious bio-based materials to reduce the use of microplastic pollutants.

Other news

• Disruptive science is leaping forward, not limping along. A more relevant metric to gauge the success of the scientific enterprise is the extent to which advances translate into real human impact.
• In synthetic biology, startups and incumbent companies should be partners, not foes. In the SynBio Age, going it alone is neither necessary nor sufficient for success, the authors write: "Only then can both generate all the benefits that the science promises."
• The Cold Spring Harbor Lab's course on Synthetic Biology is back for 2023! Submit your applications before April 1, 2023.

Regards,
John

---

John Cumbers
Founder, SynBioBeta

Who's hiring?

• Senior Customer Program Manager at MicroByre, Berkeley/Oakland Bay Area
• Scientist – Fermentation, Concerto Biosciences, Cambridge, MA
• Director of Content‍, SynBioBeta
• Senior Sales Manager, SynBioBeta
• Sales Associate, SynBioBeta

View in Browser »

Like our Digest? Please feel free to share with friends, family, and co-workers!

SynBioBeta, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com

If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences